This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Nano Intelligent Biomedical Engineering Corporation Co. Ltd., Seoul National University. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 19 
1 out of 1,784 
Years Active: 2018
Title: Innovations in Obesity Treatment by In Ho Jo
Introduction
In Ho Jo, an inventive mind hailing from Chungcheongnam-do, South Korea, has made significant strides in the field of obesity treatment through his patented innovations. With a keen focus on biomedicine, his contribution to health science has opened new avenues for preventing and treating obesity.
Latest Patents
In Ho Jo holds a noteworthy patent titled "Fat accumulation inhibitory peptide and pharmaceutical composition for preventing or treating obesity containing the same." This invention discloses a fat accumulation inhibitory peptide primarily comprised of an amino acid sequence represented by SEQ ID NO: 1. The pharmaceutical composition is crafted specifically for preventing and treating obesity, demonstrating great potential in combating this modern health issue. The peptide has proven functionality in inhibiting the differentiation of mesenchymal stem cells into adipocytes, effectively reducing adipose tissue accumulation. Thus, it serves as a valuable tool in the prevention and treatment of obesity.
Career Highlights
Throughout his career, In Ho Jo has been associated with prominent organizations that foster innovation and research in biotechnology. He has contributed his expertise as part of the Seoul National University R&D Foundation and the Nano Intelligent Biomedical Engineering Corporation. His work at these institutions has significantly contributed to the scientific community's understanding of obesity and its treatments.
Collaborations
In Ho Jo has collaborated with esteemed colleagues, including Chong-Pyoung Chung and Yoon Jeong Park. Their collective efforts have enriched the research landscape and enhanced the efficacy of their innovative approaches to health and medicine.
Conclusion
In Ho Jo's innovation is a testament to the potential of scientific research and his commitment to improving health outcomes. His patented peptide represents a significant advancement in obesity treatment, promising a healthier future for many individuals. As research progresses, his contributions will likely continue to influence the field and inspire further innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile